| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 1.486 | 3.169 | 823 | 102.572 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 1.566 | 3.131 | 823 | 102.578 | 0 |
| Total Expenses - EUR | - | - | - | - | 1.573 | 2.093 | 1.474 | 860 | 96.266 | 219 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.573 | -527 | 1.657 | -37 | 6.312 | -219 |
| Net Profit/Loss - EUR | - | - | - | - | -1.573 | -572 | 1.639 | -54 | 5.354 | -219 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bella-Vita Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 429 | 4.009 | 6.967 | 7.816 | 85.025 | 10.388 |
| Inventories | - | - | - | - | 0 | 1.412 | 3.574 | 4.150 | 0 | 0 |
| Receivables | - | - | - | - | 374 | 1.349 | 2.437 | 1.483 | 79.977 | 536 |
| Cash | - | - | - | - | 56 | 1.248 | 956 | 2.183 | 5.048 | 9.852 |
| Shareholders Funds | - | - | - | - | -520 | -1.081 | 582 | 530 | 5.882 | 5.630 |
| Social Capital | - | - | - | - | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | - | - | - | - | 1.034 | 5.200 | 6.431 | 7.286 | 79.143 | 4.758 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Bella-Vita Medical S.r.l.